Page last updated: 2024-11-05

xylazine and Diabetes Mellitus, Type 1

xylazine has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordon, CS1
Serino, AS1
Krause, MP1
Campbell, JE1
Cafarelli, E1
Adegoke, OA1
Hawke, TJ1
Riddell, MC1

Other Studies

1 other study available for xylazine and Diabetes Mellitus, Type 1

ArticleYear
Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy?
    PloS one, 2010, Nov-17, Volume: 5, Issue:11

    Topics: Adolescent; Analgesics; Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Humans; Ketamine

2010